Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain. - Wikidata - awgldk - TriplyDB

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

http://www.wikidata.org/entity/Q37706615

about

NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9 Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity Immunodominant fragments of myelin basic protein initiate T cell-dependent pain.Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries.Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization.Reciprocal relationship between membrane type 1 matrix metalloproteinase and the algesic peptides of myelin basic protein contributes to chronic neuropathic pain.CCN3: the-pain-killer inside me.Acute- and late-phase matrix metalloproteinase (MMP)-9 activity is comparable in female and male rats after peripheral nerve injury.

P2860

Q28582114-0458FDA0-2067-4D1B-97E9-AE86950443D4 Q34360507-A80E4CE6-EB96-48AF-B10E-0337ECF9B8EE Q36156744-E9F4653F-981E-4F1E-9CE8-E4E77FAD8672 Q36222825-763624EC-69B8-4FBA-ABD6-6A5B8B738440 Q36227084-D5707934-4547-49AB-8E98-91355F584352 Q39197809-969819BD-3117-435B-B2EA-071CC25B90A7 Q42182664-FB91B810-600F-4928-8387-11B40A9F41BD Q51737713-265D05CD-9B4F-437A-859B-A02C925BA517

P2860

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

http://www.wikidata.org/entity/Q37706615

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

@en

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

@nl

type

label

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

@en

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

@nl

prefLabel

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

@en

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

@nl

P1433

Q37706615-1D58433A-DDFD-4FD6-86BB-0A1F412C06C6

P1476

Q37706615-8E8491D8-64F5-49E7-BD8D-1E61DE42E96D

P2093

Q37706615-3C965B1B-17D8-4787-AECC-ED6D6990BDE3

Q37706615-804635D7-3F41-4516-813F-E261677D74CD

Q37706615-D9B750AD-E475-45CE-8CDA-F12B30BB9042

Q37706615-E7A5AAF3-26AE-46D8-B8EA-2DD870FDF7F0

Q37706615-FEE55F30-2E0F-4E84-BDB6-704585D20939

P2860

Q37706615-00F9098A-50D1-4868-BBC5-DFA68327AD49

Q37706615-01986C69-8F0C-4C16-864E-9A73CD0C70DE

Q37706615-086F375B-6C1D-491D-97E6-FFDFA5090DA7

Q37706615-10515C4F-35F9-4684-86CE-D6C5591BB9EB

Q37706615-11C13024-2BC4-436A-8096-7A5281644BB2

Q37706615-1200501E-1BEA-4DC1-A928-7F474517314E

Q37706615-156855EE-60FF-4DEE-A6DA-B59BAA0817AE

Q37706615-1584C0A7-C632-41EE-8811-B9DEAEE51E6B

Q37706615-1590E8F6-B9F9-490D-B6F6-1320C1B950E4

Q37706615-18E8FD5F-6A56-43F7-AA94-FD76BB489A24

P304

Q37706615-43BFD20A-8E49-4F99-869D-A485E3AEBA1D

P31

Q37706615-E25EA5E6-C0E2-413D-AFBA-8F487CF96287

P356

Q37706615-48A737CB-9CCD-43EE-B3D7-830DDA4BDFC0

P407

Q37706615-5EB840A0-B018-47B9-8446-DF7553EF9BB2

P433

Q37706615-FB77EB3E-3E3A-4313-AC5B-11D8A3CFFC7F

P478

Q37706615-6EC122AD-765B-4024-A4B7-D6611D80DDEB

P577

Q37706615-5E857670-D5F9-4CEA-9DE9-DFFCB8B2D6D9

P698

Q37706615-D8B5243C-F722-4013-83DA-5DBB86455215

P921

Q37706615-D695AD79-22E6-4687-AF3F-C13FD13B4DBC

P356

13543781003643486

P1433

Expert Opinion on Investigational Drugs

P1476

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

@en

P2093

Abhijit Ray

http://www.w3.org/2001/XMLSchema#string

Jitesh P Iyer

http://www.w3.org/2001/XMLSchema#string

Punit Kumar Srivastava

http://www.w3.org/2001/XMLSchema#string

Rishabh Dev

http://www.w3.org/2001/XMLSchema#string

Sunanda G Dastidar

http://www.w3.org/2001/XMLSchema#string

P2860

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

A matrix metalloproteinase expressed on the surface of invasive tumour cells

Pathological and protective roles of glia in chronic pain

An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse

Structure and regulation of voltage-gated Ca2+ channels

Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'

Post-herpetic neuralgia and topical capsaicin

Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation

Clinical Effectiveness and Cost-Effectiveness of Treatments for Patients With Chronic Pain

Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy.

P304

455-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543781003643486

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20218929

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain